$145.27
0.55% yesterday
NYSE, Dec 23, 10:06 pm CET
ISIN
US4781601046
Symbol
JNJ

Johnson & Johnson Stock price

$145.27
-10.51 6.75% 1M
-3.85 2.58% 6M
-11.47 7.32% YTD
-10.19 6.55% 1Y
-22.98 13.66% 3Y
-1.17 0.80% 5Y
+40.99 39.31% 10Y
NYSE, Closing price Mon, Dec 23 2024
+0.80 0.55%
ISIN
US4781601046
Symbol
JNJ
Sector
Industry

Key metrics

Market capitalization $349.75b
Enterprise Value $365.21b
P/E (TTM) P/E ratio 24.01
EV/FCF (TTM) EV/FCF 17.60
EV/Sales (TTM) EV/Sales 4.16
P/S ratio (TTM) P/S ratio 3.99
P/B ratio (TTM) P/B ratio 4.98
Dividend yield 3.40%
Last dividend (FY24) $4.91
Revenue growth (TTM) Revenue growth -8.03%
Revenue (TTM) Revenue $87.69b
EBIT (operating result TTM) EBIT $21.57b
Free Cash Flow (TTM) Free Cash Flow $20.75b
Cash position $20.30b
EPS (TTM) EPS $6.05
P/E forward 20.87
P/S forward 3.94
EV/Sales forward 4.11
Short interest 0.77%
Show more

Create a Free Account to create an Johnson & Johnson alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Johnson & Johnson Stock Analysis

Analyst Opinions

24 Analysts have issued a Johnson & Johnson forecast:

11x Buy
46%
13x Hold
54%

Analyst Opinions

24 Analysts have issued a Johnson & Johnson forecast:

Buy
46%
Hold
54%

Financial data from Johnson & Johnson

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
87,691 87,691
8% 8%
100%
- Direct Costs 27,474 27,474
10% 10%
31%
60,217 60,217
7% 7%
69%
- Selling and Administrative Expenses 14,940 14,940
14% 14%
17%
- Research and Development Expense 16,419 16,419
12% 12%
19%
28,858 28,858
12% 12%
33%
- Depreciation and Amortization 7,286 7,286
2% 2%
8%
EBIT (Operating Income) EBIT 21,572 21,572
15% 15%
25%
Net Profit 14,684 14,684
8% 8%
17%

In millions USD.

Don't miss a Thing! We will send you all news about Johnson & Johnson directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Johnson & Johnson Stock News

Positive
Seeking Alpha
4 days ago
Johnson & Johnson's diversified revenue streams, significant presence in oncology and immunotherapy, and aggressive growth investments make it a strong defensive play. The company's low leverage, ample liquidity, and impressive free cash flow margin support its dividend sustainability and long-term growth. The stock is very attractively valued with an 18% potential upside.
Positive
24/7 Wall Street
5 days ago
The Dow Jones industrial average is a price-weighted index of 30 blue-chip U.S.
Positive
Seeking Alpha
5 days ago
The June/July, 2024 Fortune Magazine revealed 500 biggest U.S. companies by-revenue and profits. Arnold-research focused on 66 December industry-leaders using YCharts 12/13/24 data for Profits from 63. Those 63 Fortune 500 industry leaders (F500IL) were segmented into 21 business sectors ranging (alphabetically) from aerospace/defense to wholesalers. By yield, MO topped-all F500IL. Top-ten Yiel...
More Johnson & Johnson News

Company Profile

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Head office United States
CEO Joaquin Duato
Employees 131,900
Founded 1887
Website www.jnj.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today